134 related articles for article (PubMed ID: 19406119)
1. Does telmisartan prevent hepatic fibrosis in rats with alloxan-induced diabetes?
Halici Z; Bilen H; Albayrak F; Uyanik A; Cetinkaya R; Suleyman H; Keles ON; Unal B
Eur J Pharmacol; 2009 Jul; 614(1-3):146-52. PubMed ID: 19406119
[TBL] [Abstract][Full Text] [Related]
2. Effect of telmisartan on the expression of cardiac adiponectin and its receptor 1 in type 2 diabetic rats.
Guo Z; Zheng C; Qin Z; Wei P
J Pharm Pharmacol; 2011 Jan; 63(1):87-94. PubMed ID: 21155820
[TBL] [Abstract][Full Text] [Related]
3. Effect of telmisartan on VEGF-induced and VEGF-independent angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ)-induced diabetic rats.
Chaudagar KK; Mehta AA
Clin Exp Hypertens; 2014; 36(8):557-66. PubMed ID: 24490705
[TBL] [Abstract][Full Text] [Related]
4. Telmisartan, an angiotensin II type 1 receptor blocker, prevents the development of diabetes in male Spontaneously Diabetic Torii rats.
Hasegawa G; Fukui M; Hosoda H; Asano M; Harusato I; Tanaka M; Shiraishi E; Senmaru T; Sakabe K; Yamasaki M; Kitawaki J; Fujinami A; Ohta M; Obayashi H; Nakamura N
Eur J Pharmacol; 2009 Mar; 605(1-3):164-9. PubMed ID: 19171132
[TBL] [Abstract][Full Text] [Related]
5. Ameliorative effects of telmisartan in diabetic rats with indomethacin-induced gastric ulceration.
Fouad AA; Al-Sultan AI; Yacoubi MT; Gomaa W
Eur J Pharmacol; 2010 Jul; 637(1-3):162-70. PubMed ID: 20399771
[TBL] [Abstract][Full Text] [Related]
6. Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.
Lakshmanan AP; Watanabe K; Thandavarayan RA; Sari FR; Harima M; Giridharan VV; Soetikno V; Kodama M; Aizawa Y
Free Radic Res; 2011 May; 45(5):575-84. PubMed ID: 21381899
[TBL] [Abstract][Full Text] [Related]
7. Effect of telmisartan on expression of protein kinase C-alpha in kidneys of diabetic mice.
Yao LJ; Wang JQ; Zhao H; Liu JS; Deng AG
Acta Pharmacol Sin; 2007 Jun; 28(6):829-38. PubMed ID: 17506942
[TBL] [Abstract][Full Text] [Related]
8. Telmisartan ameliorates germ cell toxicity in the STZ-induced diabetic rat: studies on possible molecular mechanisms.
Kushwaha S; Jena GB
Mutat Res; 2013 Jul; 755(1):11-23. PubMed ID: 23648321
[TBL] [Abstract][Full Text] [Related]
9. Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes.
Qiang G; Zhang L; Yang X; Xuan Q; Shi L; Zhang H; Chen B; Li X; Zu M; Zhou D; Guo J; Yang H; Du G
Eur J Pharmacol; 2012 Jun; 685(1-3):156-64. PubMed ID: 22546234
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes.
Goyal SN; Bharti S; Bhatia J; Nag TC; Ray R; Arya DS
Diabetes Obes Metab; 2011 Jun; 13(6):533-41. PubMed ID: 21320264
[TBL] [Abstract][Full Text] [Related]
11. Dual therapy versus monotherapy of trandolapril and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats.
Rao RP; Jain A; Srinivasan B
J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):169-75. PubMed ID: 21421651
[TBL] [Abstract][Full Text] [Related]
12. Renoprotective activity of telmisartan versus pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats.
Tawfik MK
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):600-9. PubMed ID: 22774400
[TBL] [Abstract][Full Text] [Related]
13. The effects of telmisartan on mechanical responses of left ventricular papillary muscle in rats with streptozotocin-induced diabetes mellitus.
Emre M; Kavak S; Unlugenc H
Acta Diabetol; 2010 Dec; 47 Suppl 1():153-9. PubMed ID: 19855921
[TBL] [Abstract][Full Text] [Related]
14. Combination of aspirin with telmisartan suppresses the augmented TGFbeta/smad signaling during the development of streptozotocin-induced type I diabetic nephropathy.
Mulay SR; Gaikwad AB; Tikoo K
Chem Biol Interact; 2010 Apr; 185(2):137-42. PubMed ID: 20223228
[TBL] [Abstract][Full Text] [Related]
15. Modulation of PPAR-gamma by telmisartan protects the heart against myocardial infarction in experimental diabetes.
Goyal S; Arora S; Bhatt TK; Das P; Sharma A; Kumari S; Arya DS
Chem Biol Interact; 2010 May; 185(3):271-80. PubMed ID: 20307515
[TBL] [Abstract][Full Text] [Related]
16. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
Xu W; Song S; Huang Y; Gong Z
J Gastroenterol Hepatol; 2006 Aug; 21(8):1250-6. PubMed ID: 16872305
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan inhibited angiotensin II-induced collagen metabolic imbalance without directly targeting TGF-β 1/Smad signaling pathway in cardiac fibroblasts.
Zhang Y; Zhao NA; Wang JK; Zhu SM; Zhu HL; Liu B; Cui QW; Guan GC; Tian G
Minerva Cardioangiol; 2015 Dec; 63(6):507-14. PubMed ID: 26657532
[TBL] [Abstract][Full Text] [Related]
18. Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice.
Iwanami J; Mogi M; Tsukuda K; Min LJ; Sakata A; Jing F; Iwai M; Horiuchi M
J Hypertens; 2010 Aug; 28(8):1730-7. PubMed ID: 20498620
[TBL] [Abstract][Full Text] [Related]
19. H2AK119 monoubiquitination regulates Angiotensin II receptor mediated macrophage infiltration and renal fibrosis in type 2 diabetic rats.
Pandey A; Goru SK; Kadakol A; Malek V; Sharma N; Gaikwad AB
Biochimie; 2016 Dec; 131():68-76. PubMed ID: 27693081
[TBL] [Abstract][Full Text] [Related]
20. AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats.
Wenzel P; Schulz E; Oelze M; Müller J; Schuhmacher S; Alhamdani MS; Debrezion J; Hortmann M; Reifenberg K; Fleming I; Münzel T; Daiber A
Free Radic Biol Med; 2008 Sep; 45(5):619-26. PubMed ID: 18539157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
